INS and cancer: Moreover, the insulin/IGF system has also been implicated in cancer metabolism, the acquisition of cancer drug resistance, as well as with cancer stem cell (CSC) phenotypes [6,7], which altogether highlight the importance of this system in the regulatory networks that occur during the processes of cancer development and progression.